Work

1190 Silen-c2: Early Antiviral Activity and Safety of Bi 201335 Combined With Peginterferon Alfa-2a and Ribavirin (pegifn/rbv) in Chronic Hcv Genotype-1 Patients With Non-response to Pegifn/rbv

Year: 2010

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(10)61191-9

Authors: M. Sulkowski, M. Bourliere, J.-P. Bronowicki, A. Streinu-Cercel, L. Preotescu, T. Asselah, J.-M. Pawlotsky, S. Shafran, S. Pol, F.A. Caruntu, S. Mauss, D. Larrey, C. Häfner, Y. Datsenko, J. Stern, R. Kubiak, G. Steinmann

Institutions: Georgetown University Medical Center, Infectious Diseases and the Research Institute, Romark (United States), Bristol-Myers Squibb (United States), Saint Louis University Hospital, Hôpital Cochin, Saint Louis University, Yale University, Stanford Medicine, Methodist Dallas Medical Center, Stanford University, Florida Center for Gastroenterology

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2001244116

FWCI: 3.575

Cites:

Cited by: 22

Related to: 10